China Supply Chain Executive Summit 2018 June 21-22, 2018 

The 2018 China Supply Chain Executive Summit (CSCES 2018), organized by Conways Asia, will be held in Beijing, China during June 21-12, 2018 and supported by influential and authoritative associations, media and governments. And now after yearly and successfully held, the CSCES series summits have already been the landmark for supply chain area in Asia.

CSCES as the most influential supply chain gala with a global perspective, in-depth discussion of the domestic and international supply chain trends and issues. More than 500 supply chain, logistic, Channel heads from industries like FMCG, electronics, E-commerce, Internet, artificial intelligence, big data, aerospace, etc. will gather for the superb opportunity for conversation, collaboration, and networking.



Why Get Involved?

China Supply Chain Executive Summit 2018 Beijing

+
At the scene of the summit
  • Commercial Talk in Exhibition Area
  • Q&A and Brainstorming
  • In-depth Discussions and Case Sharing
  • Communication and Coordination
KEY TOPICS TO BE DISCUSSED IN CSCES2018

l  19th CPC National Congress - Supply chain innovation-driven development of high quality, Building modern supply chains together

l  Supply Chain Globalization: Challenges and Responses

l  The Secret to Supply Chain Success: Achieving Agility & Flexibility in a Volatile Global Marketplace

l  S&OP Focus

l  The trends of Supply Chain Transparency in The information age

l  Prospects and trends of Supply Chain Finance

l  The Journey of End-to-End Supply Chain Mapping

l  Digital Trendsetters: the most successful digital supply chains

l  Creating Smart Supply Chains for the New Retail Era

l  Blockchain technology driven supply chain management reformation

l  How to integrate logistics network optimization into enterprise strategy

l  How the enterprises will make use of the shared economy and the data collaboration to Integration of logistics and warehousing

l  How Artificial Intelligence Will Change The Supply Chain Game

Participating Enterprises, Governments and Associations

Unilever, BOE, Alibaba, OFO, Boeing, Jumei.com, China Huaneng Group, Yanjing Beer, BMW, Yili Group, 3M, Nike, COFCO, Intel, Michelin,Lining, Coca-Cola, Shell, Procter & Gamble, FOTON, L'Oreal, Samsung, PepsiCo, H & M, Tsinghua Tonngfanng Co, Master Kong, Wangfujing Group, Cisco, China tobacco, Kimberly-Clark, Mars, Starbucks, BYD, Dior, JD.com, Tsingtao Brewery, Xiaomi, HP, BASF, Richemont, Nestle, Haier, Stanley Paterson, Vestas,Estee Lauder, Sinopec, Adidas, Mengniu, Inditex, McDonald's, JCC, Swatch Group, Apple, Giant Tire, Gree, Family Mart, Chanel, ZTE, Vipshop, Schneider Electric, China Metallurgical Group, Huawei, Toyota, Rosen, Amazon, Shuanghui Group, Bailian, Laiyifen, GAP, Shanghai Pharmaceutical, Wal-Mart, Johnson & Johnson, Lenovo, Suning, CNPC, Philips, Midea, Masayoshi, Canon, Pfizer, GSK, Vanke Group, New Hope Liuhe, Ping An Bank, Ericsson, Foxconn, Mindray, China Resources Pharmaceutical group, Zoomlion...


SPEAKRS
MORE
SPONSORS & PARTNERS
  • Associate Sponsors
  • Presentation Sponsors
  • Exhibition Sponsors
JOIN THEM
Prof.bin yangDirector
China institute of FTZ Supply Chain – FTZ institute of regulatory services
×
        Mr. Alex Liu received his M.S. degree in molecular pharmacology from Peking Union Medical Collage and an LLM degree in IP Law from Franklin Pierce Law School (US). Mr. Liu is qualified both as a patent attorney in China and a patent agent in the US. As an experienced patent practitioner working in a multi-national company in China, Mr. Liu is adept at developing IP strategies and managing IP portfolios that position businesses to take advantage of both legal and business opportunities.


        As part of his previous practice as an external counsel, Mr. Liu provided expert advice on issues including patentability, validity, infringement, freedom-to-operate, due diligence, etc. After joining Bayer China since 2007, Mr. Liu also helped his company draft and negotiate technology transfer agreements, IP licensing agreements, and other contracts related to IP transaction in the areas of pharmaceuticals, agrichemicals, biotechnology, and medical devices. As now being the IP Head of Bayer China since 2013, he is conducting/coordinating all types of IP issues for the company in the APEC region.